Back to Agenda
Digital Channels and Artificial Intelligence in Medical Information and Communications
Session Chair(s)
Peter Baumeister, PhD
Director, Global Medical and Scientific Affairs
Merck Sharp & Dohme LLC , United States
This session will inform the attendee on the current state of artificial intelligence and its potential for use in the medical affairs/information/communication space. In relation to digital channels, this session will explore customer usage and preferences (health care provider and consumer), what does good look like in this space (including pharmaceutical medical information websites), what is the payoff for pharma's investment in this area (i.e., where should resources be focused.)
Learning Objective : Describe the possibilities and limitations for use of artificial intelligence in medical information and communications; Identify what good looks like in the medical information digital space.
Speaker(s)
Panelist
Ron Segal, MBA, PMP
Pfizer Inc., United States
Senior Director, Business Technology
Artificial Intelligence
Joseph D. Scrocco, MBA, MS
OneWorld Inc., United States
President and CEO
Have an account?